Daniel Lagasse InspectorProfile


This InspectorProfile is a report of relevant audit-related information on Daniel Lagasse, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Biologics.

Product Description

This InspectorProfile report is updated through and lists Daniel Lagasse's 1 inspections in 1 countries: and United States .

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Daniel Lagasse's inspection information so that you can mitigate investigator-related risks.

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Daniel Lagasse.

Example Report

Daniel Lagasse FDA InspectorProfile Overview Example
Daniel Lagasse FDA InspectorProfile Metrics Example
Daniel Lagasse FDA InspectorProfile Citations Example
Daniel Lagasse FDA InspectorProfile Inspections List
Add To Cart1 of Lagasse 483s in stock

Product details

  • Daniel Lagasse's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Daniel Lagasse has conducted including:
    • Company, site inspected, duration of inspection
    • Co-inspectors like Prabhu Raju FDA, Zuben Sauna FDA, Linda Thai FDA, year of last co-inspection, number of co-inspections
    • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.

Add To Cart1 of Daniel's 483s Available Now.